| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 130.452 | 124.841 | 643.507 | 1.908.080 | 771.841 | 1.726.395 | 53.638 | 935.916 |
| Total Income - EUR | - | - | 130.452 | 124.841 | 643.507 | 1.908.104 | 805.032 | 1.727.699 | 53.705 | 935.916 |
| Total Expenses - EUR | - | - | 66.025 | 137.579 | 432.707 | 1.631.003 | 719.664 | 1.202.304 | 50.288 | 737.516 |
| Gross Profit/Loss - EUR | - | - | 64.426 | -12.738 | 210.799 | 277.101 | 85.369 | 525.395 | 3.417 | 198.400 |
| Net Profit/Loss - EUR | - | - | 63.122 | -14.008 | 205.418 | 256.480 | 77.343 | 507.127 | 2.826 | 171.428 |
| Employees | - | - | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Unimix Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 12.966 | 26.095 | 17.515 | 11.603 | 60.743 | 44.602 | 31.352 | 152.149 |
| Current Assets | - | - | 72.955 | 40.978 | 278.911 | 1.022.584 | 235.200 | 1.076.868 | 387.060 | 1.322.269 |
| Inventories | - | - | 109 | 107 | 1.224 | 3.143 | 21.886 | 11.102 | 24.317 | 0 |
| Receivables | - | - | 11 | 36.924 | 75.021 | 985.850 | 152.464 | 978.413 | 297.773 | 1.048.546 |
| Cash | - | - | 72.834 | 3.946 | 202.666 | 33.592 | 60.850 | 87.353 | 64.970 | 273.723 |
| Shareholders Funds | - | - | 63.165 | 20.854 | 225.868 | 261.537 | 91.258 | 521.085 | 15.947 | 171.476 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 22.755 | 46.220 | 70.558 | 772.650 | 204.685 | 600.385 | 418.741 | 1.302.942 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Unimix Medical S.r.l.